Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7274 p644-645
8 November 2003

This page
Reprint
Photocopy

   

PDF* 95K

Letters

  Modernisation
  The Register
  Ramipril
  Needle exchange


Letters to the Editor

The Register

Why a dispensing register could solve problems

From Mr P. I. Herman, MRPharmS

It would seem to me sensible that the requirements for membership of the Society should remain as they are; however, a “dispensing register” should be created. Those members who wish to engage in National Health Service dispensing — hospital, community or electronic — would undertake to complete approved continuing professional development.

Those members who do not wish to dispense, for reasons of age, infirmity, career breaks, etc, could remain as members of the Society and not lose the valuable contributions they could make. In addition, members in the academic, managerial and industrial side of the profession could retain membership without incurring the costs in time and money of being on the dispensing register.

The costs of maintaining and regulating the dispensing register should be met one-third by the pharmacists registered and two-thirds by a premises fee levied on all pharmacies registered with the Society. Since it is the Government that is demanding changes to the Register, premises fees should be fully reimbursed by the NHS and income to the Society from other sources, such as publishing, could be used to keep non-dispensing members’ fees down. Members on the dispensing register would elect from their own ranks the members to serve on the regulatory supervision body in broad accordance with Government requirements.

To sum up, I believe my proposals would be inclusive of the whole range of pharmaceutical activities, retain members who have only a sentimental attachment to the profession, or are in reduced circumstances, and allow flexibility for those wishing to return to the dispensing register to do so by simply undertaking the required CPD. Additionally, the costs of regulation will be highlighted allowing for authoritative reimbursement claims against the Government.

P. I. Herman
London W11

Send your letter to The Editor

Previous Topic (Modernisation)
Next Topic (Ramipril)

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal